Tweet #172730280891785216

Zelboraf (Vemurafenib) Doubles Survival Times For Metastatic Melanoma Patients. #skincancer
mnt.to/44Qy via @mnt_skincancer

From Twitter for Websites 12:11pm Feb 23 2012 —